Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding

Journal of Cerebral Blood Flow and Metabolism

Volumn 18, Issue 9, 1998, Pages 941-950

  Ito, Hiroshi ^a,b   Hietala, Jarmo ^a,c   Blomqvist, Gunnar ^a   Halldin, Christer ^a   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

D2 dopamine receptors; Positron emission tomography 11C Raclopride; Transient equilibrium

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ADULT; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; COMPARTMENT MODEL; CONTINUOUS INFUSION; DATA ANALYSIS; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; LIGAND BINDING; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ADULT; CARBON RADIOISOTOPES; CHEMISTRY; DOPAMINE ANTAGONISTS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; RACLOPRIDE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SALICYLAMIDES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031784781     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199809000-00003     Document Type: Review

References (39)

1. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB (1994) SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35:228-238
2. Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 5:136-141
3. 2 receptors in humans using positron emission tomography. Eur J Nucl Med 21:937-946
4. Blomqvist G, Pauli S, Farde L, Eriksson L, Persson A, Halldin C (1990) Maps of receptor binding parameters in the human brain: a kinetic analysis of PET measurements. Eur J Nucl Med 16:257-265
5. 11C-raclopride and positron emission tomography. Ann Neurol 31:184-192
6. 11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17:437-447
7. 18F]cyctofoxy and positron emission tomography. J Cereb Blood Flow Metab 13:24-42
8. Crone C (1963) Permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 58:292-305
9. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B (1988) Automatic blood sampling systems for positron emission tomography. IEEE Trans Nucl Sci 35:703-707
10. Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedstrom CG, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863-3867
11. 2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696-708
12. 2 dopamine receptor binding in the living human brain by PET. Science 231:258-261
13. Halldin C, Swahn CG, Farde L, Sedvall G (1995) Radioligand disposition and metabolism: key information in early drug development. In: PET for Dnig Development and Evaluation (Comer D, ed), The Netherlands, Kluwer Academic Publisher, pp 55-65
14. Huang SC, Barrio JR, Phelps ME (1986) Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J Cereb Blood Flow Metab 6:515-521
15. D with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat. J Cereb Blood Flow Metab 11:529-544
16. 11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J Cereb Blood Flow Metab 10:727-739
17. 3H-raclopride: a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259
18. 11C]raclopride studies. J Cereb Blood Flow Metab 16:42-52
19. 123l]iomazenil binding to benzodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J Cereb Blood Flow Metab 14:453-465
20. Lassen NA (1992) Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J Cereb Blood Flow Metab 12:709-716
21. Leenders KL, Perani D, Lammerstsma AA, Heather JD, Buckingham P, Healy MJ, Gibbs JM, Wise RJ, Hatazawa J, Herold S, Beaney RP, Brooks DJ, Spinks T, Rhodes C, Frackowiak RSJ, Jones T (1990) Cereb blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain 113:27-47
22. Lenzi GL, Frackowiak RS, Jones T (1982) Cereb oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 2:321-335
23. Marquardt D (1963) An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 11:431-441
24. 125I]iodosulpride, a highly selective ligand. Science 228: 752-755
25. Mintun MA, Raichle ME, Kilboum MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-227
26. 11C]raclopride binding. J Cereb Blood Flow Metab 15:5643
27. 2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33:227-235
28. 2 dopamine receptor occupancy in the living human brain: a PET study with risperidone. Psychopharmacology 110:265-272
29. Patlak CS, Pettigrew KD (1976) A method to obtain infusion schedules for prescribed blood concentration time courses. J Appl Physiol 40:458-463
30. 11C]flumazenil. J Cereb Blood Flow Metab 13:656-667
31. Renkin E (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205-1210
32. 2 receptor changes during the progression of early Parkinson's disease. Mov Disord 8:134-138
33. 15O labeled gases. Jpn J Nucl Med 23:123-134
34. 11C]SCH23390: identification of two radiolabelled metabolites with HPLC. Hum Psychophannacol 9:25-31
35. Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf AP (1993) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 34:609-613
36. Watson CC, Newport D, Casey ME (1996) A single scatter simulation technique for scatter correction in 3D PET. In: Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine (Grangeat P, Amans JL, eds), Dordrecht, The Netherlands, Kluwer Academic Publishers, pp 255-268
37. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD (1994) The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18:110-118
38. Wong DF, Gjedde A, Wagner HN Jr (1986) Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands. J Cereb Blood Flow Metab 6:137-146
39. Yamaguchi T, Kanno I, Uemura K, Shishido F, Inugami A, Ogawa T, Murakami M, Suzuki K (1986) Reduction of regional cerebral metabolic rate of oxygen during human aging. Stroke 17:1220-1228